PneumoWave’s cover photo
PneumoWave

PneumoWave

Medical Equipment Manufacturing

Eurocentral, Scotland 1,220 followers

AI-Driven Wearable Motion Sensing for Life Threatening Conditions

About us

PneumoWave is revolutionizing the response and management of life-threatening respiratory conditions with a virtual-first approach for clinicians that harnesses the power of AI. We use real-time physiological/behavioral data from our wearable biosensor to screen, monitor and alert patients at risk of life-threatening conditions.

Industry
Medical Equipment Manufacturing
Company size
11-50 employees
Headquarters
Eurocentral, Scotland
Type
Privately Held
Founded
2018

Locations

  • Primary

    Suites 3 and 4, 2nd Floor, Maxim 3, Maxim Park

    Parklands Avenue

    Eurocentral, Scotland ML1 4WQ, GB

    Get directions

Employees at PneumoWave

Updates

  • View organization page for PneumoWave

    1,220 followers

    📣 WE ARE HIRING 📣 We are currently recruiting for an R&D Test Engineer to support our ongoing development of advanced respiratory monitoring solutions. This role is central to our mission of reducing preventable deaths through real-time, clinically validated digital health technologies. Based at our Eurocentral facility in Scotland, this position offers the opportunity to contribute to a meaningful and technically challenging area of innovation within a collaborative, multidisciplinary team in a hybrid work environment. To learn more about the role, please visit: https://lnkd.in/eVZXaRuc #PneumoWave #TestEngineer #DigitalHealth #MedTech #EngineeringJobs

  • Thank you, Scottish Development International, for highlighting the role of innovative Scottish companies in tackling global healthcare challenges. We’re proud that PneumoWave’s work in respiratory monitoring is contributing to efforts that support early intervention and prevent avoidable deaths, particularly in the context of opioid-related harm. It's encouraging to see Scotland recognised as a leader in healthtech - driven by collaboration between clinicians, researchers, and industry. We look forward to continuing this important work alongside our peers in the sector.

    With the rising demands on healthcare services, particularly from opioid addiction, which is projected to affect 2.49 million more people globally by 2027, the need for efficient, cost-effective care solutions is greater than ever 🏥💸 In Scotland, remote monitoring technologies are playing a crucial role in improving the health of patients living with drug addictions and chronic conditions. These technologies, integrated with AI and IoT, offer early intervention tools that reduce hospital admissions and allow for more proactive care, especially for conditions like chronic obstructive pulmonary disease (COPD), which are often linked to regular opioid use. With companies like Lenus Health and PneumoWave developing cutting-edge remote monitoring solutions, Scotland is emerging as a leader in healthtech innovation. Lenus Stratify uses AI models to identify signs of deteriorating health and predict hospital admissions for COPD patients, while PneumoWave’s device monitors chest movements to prevent sudden deaths from opioid overdoses. Craig Turpie, co-founder and COO at Edinburgh-based Lenus Health explains,“By making connections between different data that resides within healthcare systems, and data generated by patients themselves, it creates the potential for more sophisticated models and AI to be developed that can provide more accurate predictive analytics. I think the convergence of AI, big data that sits in health record systems, genomics and IoT is going to continue to push the boundaries of what remote monitoring technology can achieve.” In GlobalData Healthcare's latest article, discover how these cutting-edge technologies are reducing pressure on healthcare services, and how Scotland, with its strong academic, governmental, and clinical support, is becoming a global hub for healthtech innovation 👉 https://ow.ly/7Kv250VHBbe #ScotlandIsNow #HealthCare #MedTech

    • AI style image of someone monitoring their health using a mobile phone, and digital images appearing around their phone
  • View organization page for PneumoWave

    1,220 followers

    We’re pleased to share that PneumoWave has received Class II FDA 510(k) clearance for our Data Collection Mobile (DCM) system - a significant regulatory milestone that strengthens our position in the digital health and respiratory care markets. This clearance affirms the depth of our technical, clinical, and regulatory capabilities. Our DCM system - encompassing hardware, software, cybersecurity, usability, and risk management - underwent rigorous FDA scrutiny and was cleared with virtually no objections. This first US clearance is for sleep and activity monitoring with our Biosensor worn on the wrist; it represents a critical step forward in our broader product development strategy and demonstrates strong regulatory confidence in our engineering and ISO 13485 certified quality system. It’s the foundation we need for our chest-worn system that detects breathing trouble in real time. We’re proud of the dedication shown by our engineering, clinical, human factors and regulatory teams in achieving this milestone. It reinforces our trajectory toward scalable, real-time respiratory monitoring solutions with potential global impact. #FDA510k #MedicalDevices #RespiratoryCare #DigitalHealth #PneumoWave #MedTech

    • No alternative text description for this image

Similar pages

Browse jobs

Funding